Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. D 9998
2. D-9998
3. Ethyl 2-amino-6-((p-fluorobenzyl)amino)-3-pyridinecarbamate
4. Flupirtin Maleate
5. Flupirtine
6. Flupirtine Maleate (1:1)
7. Katadolon
1. 75507-68-5
2. Katadolon
3. Flupirtine Maleate Salt
4. Flupirtine (maleate)
5. Flupirtine Maleate [usan]
6. D-9998
7. 75507-68-5 (maleate).
8. W-2964m
9. 0vci53pk4a
10. Ethyl (2-amino-6-((4-fluorobenzyl)amino)pyridin-3-yl)carbamate Maleate
11. Ethyl 2-amino-6-((p-fluorobenzyl)amino)-3-pyridinecarbamate Maleate (1:1)
12. Ncgc00093935-01
13. Flupirtine Maleate (usan)
14. Dsstox_cid_25771
15. Dsstox_rid_81113
16. Dsstox_gsid_45771
17. Carbamic Acid, (2-amino-6-(((4-fluorophenyl)methyl)amino)-3-pyridinyl)-, Ethyl Ester, (z)-2-butenedioate (1:1)
18. D 9998
19. Flupirtin-maleat
20. Flupirtin-maleat [german]
21. (z)-but-2-enedioic Acid;ethyl N-[2-amino-6-[(4-fluorophenyl)methylamino]pyridin-3-yl]carbamate
22. Cas-75507-68-5
23. W 2964m
24. Ncgc00015451-03
25. Einecs 278-225-0
26. Unii-0vci53pk4a
27. Flupirtinmaleat
28. Effirma
29. Flupirtinemaleate
30. Katadolon Maleate
31. Flupirtinte Maleate
32. Carbamic Acid, [2-amino-6-[[(4-fluorophenyl)methyl]amino]-3-pyridinyl]-, Ethyl Ester, (z)-2-butenedioate (1:1)
33. Flupirtine Maleate- Bio-x
34. 2-amino-3-(ethoxycarbonylamino)-6-(4-fluorobenzylamino)pyridine Maleate Salt
35. Ethyl-n-(2-amino-6-(4-fluorophenylmethylamino)pyridin-3-yl)carbamate Maleate
36. (2-amino-6-(((4-fluorophenyl)methyl)amino)-3-pyridinyl)carbamic Acid Ethyl Ester Maleate
37. Ethyl-n-(2-amino-6-(4-fluor-phenylmethylamino)pyridin-3-yl)carbamat Maleat [german]
38. Schembl124707
39. Flupirtine Maleate [mi]
40. Chembl1256752
41. Dtxsid8045771
42. Flupirtine Maleate [vandf]
43. Hms3261n15
44. Flupirtine Maleate [mart.]
45. Flupirtinte Maleate [vandf]
46. Diethyl4-fluorophenylmalonate
47. Flupirtine Maleate [who-dd]
48. Tox21_111232
49. Tox21_113397
50. Tox21_500547
51. Ac-454
52. Mfcd00941415
53. Akos024286722
54. Ethyl-n-(2-amino-6-(4-fluor-phenylmethylamino)pyridin-3-yl)carbamat Maleat
55. Tox21_111232_1
56. Bcp9000699
57. Ccg-221851
58. Cs-0573
59. Lp00547
60. [2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic Acid Ethyl Ester Maleate
61. Ethyl 2-amino-6-((4-fluorobenzyl)amino)pyridine-3-carbamate, Compound With Maleic Acid (1:1)
62. Ncgc00015451-05
63. Ncgc00093935-02
64. Ncgc00261232-01
65. 133ap001
66. Bf164473
67. Hy-17001
68. Flupirtine Maleate Salt, >=98% (hplc)
69. Eu-0100547
70. F0736
71. D04226
72. F 8927
73. 507f685
74. A838439
75. Sr-01000075887
76. Q-101869
77. Sr-01000075887-1
78. Q27231153
79. 2-amino-6-[[(4-fluorophenyl)methyl]amino]-3-pyridinyl]-carbamic Acid, Ethyl Ester Maleate
80. N-[2-amino-6-[[4-fluorophenyl)methyl]amino]-3-pyridinyl]carbamic Acid Ethyl Ester Maleate
81. (z)-but-2-enedioic Acid; Ethyl N-[2-azanyl-6-[(4-fluorophenyl)methylamino]pyridin-3-yl]carbamate
82. N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic Acid Ethyl Ester; (z)-2-butenedioic Acid
Molecular Weight | 420.4 g/mol |
---|---|
Molecular Formula | C19H21FN4O6 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 8 |
Exact Mass | 420.14451256 g/mol |
Monoisotopic Mass | 420.14451256 g/mol |
Topological Polar Surface Area | 164 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 469 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
87
PharmaCompass offers a list of Flupirtine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Flupirtine manufacturer or Flupirtine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flupirtine manufacturer or Flupirtine supplier.
PharmaCompass also assists you with knowing the Flupirtine API Price utilized in the formulation of products. Flupirtine API Price is not always fixed or binding as the Flupirtine Price is obtained through a variety of data sources. The Flupirtine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Katadolon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Katadolon, including repackagers and relabelers. The FDA regulates Katadolon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Katadolon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Katadolon manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Katadolon supplier is an individual or a company that provides Katadolon active pharmaceutical ingredient (API) or Katadolon finished formulations upon request. The Katadolon suppliers may include Katadolon API manufacturers, exporters, distributors and traders.
click here to find a list of Katadolon suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Katadolon DMF (Drug Master File) is a document detailing the whole manufacturing process of Katadolon active pharmaceutical ingredient (API) in detail. Different forms of Katadolon DMFs exist exist since differing nations have different regulations, such as Katadolon USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Katadolon DMF submitted to regulatory agencies in the US is known as a USDMF. Katadolon USDMF includes data on Katadolon's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Katadolon USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Katadolon suppliers with USDMF on PharmaCompass.
A Katadolon written confirmation (Katadolon WC) is an official document issued by a regulatory agency to a Katadolon manufacturer, verifying that the manufacturing facility of a Katadolon active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Katadolon APIs or Katadolon finished pharmaceutical products to another nation, regulatory agencies frequently require a Katadolon WC (written confirmation) as part of the regulatory process.
click here to find a list of Katadolon suppliers with Written Confirmation (WC) on PharmaCompass.
Katadolon Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Katadolon GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Katadolon GMP manufacturer or Katadolon GMP API supplier for your needs.
A Katadolon CoA (Certificate of Analysis) is a formal document that attests to Katadolon's compliance with Katadolon specifications and serves as a tool for batch-level quality control.
Katadolon CoA mostly includes findings from lab analyses of a specific batch. For each Katadolon CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Katadolon may be tested according to a variety of international standards, such as European Pharmacopoeia (Katadolon EP), Katadolon JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Katadolon USP).